http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-401218-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6728292a022c6c19233992ea183f2374
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
filingDate 2012-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd3feb0220ec4a666461de52a0463c91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3caab5ad5d5e72d72c61e29916b5580f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11ef9486b3fef8a5584362d0363dfec3
publicationDate 2013-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-401218-A1
titleOfInvention Fluoroalkyl esters of 1-aminoalkane phosphonic acids and their derivatives, the method of obtaining fluoroalkyl esters of 1-aminoalkane phosphonic acids and their derivatives and the use of fluoroalkyl esters of 1-aminoalkane phosphonic acids and their derivatives
abstract The invention discloses fluoroalkyl esters of 1-aminoalkane phosphonic acids and their derivatives, of the general formula I, in which R is a substituent analogous to the side chain of natural and unnatural amino acids: alanine, valine, phenylalanine, leucine, isoleucine, methionine, norvaline, homophenylalanine or amino-aminomasinic acid; RF is a fluoroalkyl chain, preferably a group -CH2CF3, -CH2CF2CF2CF3 or -CH2CF2CF2H; Y is hydrogen, a benzyloxycarbonyl group or the Bip-Val-Pro dipeptide residue. In a variation of the method of obtaining fluoroalkyl esters of 1-aminoalkanephosphonic acids and their derivatives of the general formula I, in which R is a substituent analogous to the side chain of natural and unnatural amino acids: alanine, valine, phenylalanine, leucine, isoleucine, methionine, norvaline, homophenylalanine or ; RF is a fluoroalkyl chain, preferably a group -CH2CF3, -CH2CF2CF2CF3 or -CH2CF2CF2H; Y is hydrogen, a benzyloxycarbonyl group or the Bip-Val-Pro- dipeptide residue characterized by the fact that the tri (fluoroalkyl) phosphite obtained by the reaction of fluoroalcohol and phosphorus (III) chloride is subjected to amidoalkylation in glacial acetic acid using benzyl carbamate and the appropriate aldehyde from the group: acetaldehyde, propionic, isomasyl, phenylacetic, butyral, isovalerian, 2-methylbutyric, 3-phenylpropionic or S-methyl-propionic aldehydes, followed by the synthesis of hydrobromides of fluoroalkyl esters of 1-aminoalkanephosphonic acids, in which the benzyl protective group is unlocked (Cbz), and in the next step is reacted with the Boc-Val-Pro-OH dipeptide molecule in the presence of a coupling reagent. The invention also relates to the use of fluoroalkyl esters of 1-aminoalkanephosphonic acids and their derivatives of general formula I as serine inhibitors of the chymotrypsin and elastase proteases.
priorityDate 2012-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420171529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420155947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558760
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71077

Total number of triples: 55.